| Target Price | $18.36 |
| Price | $13.71 |
| Potential |
33.92%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Chemours Co. 2027 .
The average Chemours Co. target price is $18.36.
This is
33.92%
register free of charge
$25.20
83.81%
register free of charge
$17.17
25.24%
register free of charge
|
|
| A rating was issued by 18 analysts: 11 Analysts recommend Chemours Co. to buy, 6 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Chemours Co. stock has an average upside potential 2027 of
33.92%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 5.81 | 6.10 |
| 0.45% | 4.96% | |
| EBITDA Margin | 5.77% | 13.47% |
| 54.69% | 133.53% | |
| Net Margin | -6.65% | 2.57% |
| 656.92% | 138.67% |
13 Analysts have issued a sales forecast Chemours Co. 2026 . The average Chemours Co. sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Chemours Co. EBITDA forecast 2026. The average Chemours Co. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Chemours Co. Analysts have issued a net profit forecast 2026. The average Chemours Co. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.57 | 1.04 |
| 658.70% | 140.47% | |
| P/E | 13.19 | |
| EV/Sales | 0.86 |
13 Analysts have issued a Chemours Co. forecast for earnings per share. The average Chemours Co. EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Mizuho |
Locked
➜
Locked
|
Locked | Sep 30 2026 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jul 01 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Mizuho:
Locked
➜
Locked
|
Sep 30 2026 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jul 01 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


